Commitment to Finding New Treatments
SEHRF is committed to supporting scientific research efforts that investigate the rationale for the development of promising new treatments, whether conventional or alternative, for use in patients with epilepsy.
In spite of continuing efforts, 30 to 40 percent of epilepsy patients are resistant to anti-epileptic drugs (AEDs), while more than 50 percent of AED-responsive patients suffer from adverse side effects. These numbers are higher for children with early onset forms of epilepsy.
Integrative medicine incorporates both conventional and alternative therapies. Many doctors now agree that alternative therapies can be a valuable addition to conventional medical care.
Natural products such as botanicals and cannabinoids have been shown to have benefits in the treatment of epilepsy and brain disorders. By influencing a myriad of pathways, these products are able to restore dynamic processes with minimal risk.
Nutraceuticals are pharmaceutical-grade and standardized nutrients. Derived from the terms ‘nutrition’ and ‘pharmaceutical, nutraceuticals are foods with health benefits or that are used to treat and prevent disease.